This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and middle-income countries, to discuss the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

中文翻译：

---

SARS-CoV-2控制的人类感染模型：道德规范，挑战剂产生和监管问题。

这是第二次国际生物标准化联盟COVID-19网络研讨会，汇集了来自学术界，监管机构，资助者和工业界的广泛的国际利益相关者，其中低收入和中等收入国家也有相当多的参与，以讨论如何使用受控的人类感染这些模型可加快针对严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2）疫苗的开发和市场授权评估。